November 12, 2024
November 11, 2024First interventional study designed to demonstrate the clinical utility of the TriVerity test and its impact on patient management Sunnyvale,…- October 10, 2024
- October 10, 2024Sam Ajizian, MD (Chief Medical Officer), Jamie Lewis (Chief Commercial Officer), and Laura Spencer Garth (General Counsel) Hired to Advance…
October 1, 2024Sunnyvale, Calif., October 1, 2024 — Inflammatix, a pioneering molecular diagnostics company, today presented data demonstrating the high diagnostic and prognostic…- September 12, 2024
- September 12, 2024
- September 12, 2024
- September 12, 2024Fundraise brings lead product, TriVerity™ Test, closer to commercialization following recent submission to FDA. Sunnyvale, Calif., September 12, 2024 — Inflammatix,…
- January 2, 2024
